After selling at open, I was reassured by Jon’s clarity around the results and also regarding PWS. So whilst I did crystalise some capital gains, I did get back in for well under $23 with a larger amount of shares.
It appears revised protocols for PWS and future indications will not be discussed with the FDA until potentially Q4, but I see this as minimal short term pain for significant long term gain.
Nice to see brokerage upgrades today and media coverage. Hopefully the AGM, presentations and possible insights/news tomorrow gives NEU another kick higher.
GLTAH
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins, page-89
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.280(2.28%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.52 | $12.73 | $12.26 | $8.152M | 652.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 665 | $12.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.55 | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |